VitaSpring Biomedical Co. Ltd. (VSBC)

Revenue by Segment

Financials in millions USD. Fiscal year is February - January.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jan 31, 2026	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021	Jan 31, 2020	Jan 31, 2019	Jan 31, 2018	Jan 31, 2017
Biotechnology					5.61M	248.20K	-	-	-
Apparel					-	-	15.14K	17.18K	16.23K
Total					5.61M	248.20K	15.14K	17.18K	16.23K

Revenue by Geography

Financials in millions USD. Fiscal year is February - January.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jan 31, 2026	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021	Jan 31, 2020	Jan 31, 2019	Jan 31, 2018	Jan 31, 2017
United States					5.61M	248.20K	-	-	-
China					-	-	15.14K	17.18K	16.23K
Total					5.61M	248.20K	15.14K	17.18K	16.23K

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error